Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SHRI VINAYAK PHARMALikely | 1 | ₹2.2 L |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 6 | - |
| 3 | Schedule 3 | ARIHANT MEDITECHLikely | 1 | ₹2.7 L |
| 4 | Schedule 4 | Not yet disclosed by govt.Likely | 6 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Mar 2025, 8:00 pmClosed
Inhaler CFC free with dose MD (glycopyrrote IP 9.0 mcg and formoterol fumarate 4.8 mcg and budesonid
Tiotropium 9 mcg+ formoterol 6 mcg metered dose inhaler (MDI) 200dose
Rotacap glucopyrronium 12.5 mcg+ formoterol fumarate 12 mcg pack of 30 ratacap
Respicap/rotacap formoterol 6mcg+ glucopyrronium 25 mcg+ budesonide 400 mcg
30 capsules pack
7448465
GEM/2025/B/5884197
Two Packet Bid
Inhaler CFC free with dose MD (glycopyrrote IP 9.0 mcg and
30 days
Maharashtra; Pune
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| ) | - | 2,610 | - |
Exempted
2 Mar 2025
8 Feb 2025
1 Mar 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7448465.pdf
GEM_BID
bbbbbqr_29_5_25_2025-01-29-15-10-07_8ac67cb09b4bbaca2b8e10de16619ddb.pdf
SPECIFICATION
bbbbbqr_29_5_25_2025-01-29-15-08-07_59e76e8428212722053b7818aca28e74.pdf
SPECIFICATION
bbbbbqr_29_5_25_2025-01-29-15-12-44_2373440e52433a49162db10fa4213b8f.pdf
SPECIFICATION
bbbbbqr_29_5_25_2025-01-29-15-09-49_b91d1392b161b3febb5213a9765d0c5a.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .